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Clinics and pathology 
Disease 
Only 5 cases of hematological malignancy with 
der(1;18) are reported in the literature. Four cases of 
chronic myeloproliferative disorders (CMD) (one case 
with myelodysplastic syndrome, one patient with 
CMD, unclassifiable, one with  
essential thrombocythemia (ET) coexistent with the 
JAK2 V617F mutation, one idiopathic myelofibrosis 
(IMF)) and one patient was diagnosed with multiple 
myeloma. 
Phenotype/cell stem origin 
Unknown, but may involve a myeloid progenitor cell as 
both reported cases can be grouped under myeloid 
malignancy. 
Clinics 
The first case was a 23-year old male who presented as 
myelodysplastic syndrome that rapidly progressed to 
acute myeloid leukemia, and died of neutropenic sepsis 
at induction phase.  
 
 
Partial G-banded karyotypes showing the whole-arm chromosome translocation der(1;18)(q10)(q10). 
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The second case was a 65-year old female diagnosed as 
chronic myeloproliferative disorder, unclassifiable, and 
run a chronic stable clinical course for years. 
She however suffered from recurrent pyogenic 
cutaneous infection. The patient with essential 
thrombocythemia was a 75-year-old woman receiving 
ranimustine therapy. The case with IMF was a male 
with a history of polycythemia vera (PV) and normal 
karyotype at diagnosis. 
Prognosis 
Owing to the small number of cases reported, the 
prognostic implication of der(1;18)(q10;q10) remains 
to be defined. The clinical outcome of the two reported 
cases with detailed clinica course were markedly 
different, with one having rapid downhill course and 




Found in the unbalanced form -18, + der(1;18), with 
trisomy for 1q and monosomy for 18p. 
Additional anomalies 
Sole abnormality in 3 of 4 patients with chronic 
myeloproliferative disorders; +22 reported as additional 
abnormality in a post-polycythemic myelofibrosis 




Genes involved and proteins 
Note 
Genes involved are unknown. Mechanistically, either 
trisomy 1q or monosomy 18p that results from the 
unbalanced translocation may potentially contribute to 
leukemogenesis. Whole arm chromosome 
translocations resulting in trisomy of the long arm of 
chromosome chromosome 1 have been identified with 
several partner chromosomes including chromosomes 
7, 9, 13, 15, 16 and Y in BCR-ABL-negative 
myeloproliferative neoplasms (MPN). While the 
underlying mechanisms for these chromosomal 
alterations are unclear, it is likely that chromosomes 
with large constitutive heterochromatin bands such as 
chromosome 1 may be at risk of centromeric instability 
and be predisposed to centromeric fusion with other 
chromosomes. 
These observations suggest that a gene dosage effect of 
certain chromosome 1q regions, analogous to 
numerical aberrations may be involved in disease 
pathogenesis. Additionally, deletion of 18p may also 
contribute to clonal proliferation through loss of 
putative tumor suppressor genes, analogous to 
numerical aberrations and deletions associated with 
both chronic and advanced phases of MPN. In support 
of this contention, deletions on chromosome 18p as a 
result of der(18)t(9;18)(p13;p11) and 
der(9;18)(p10;q10) associated with the JAK2 V617F 
mutation have been described with phenotypes of 
transitional PV and IMF, suggesting that 18p deletion 
may be associated with myeloproliferative disorders 
showing a high propensity to transformation. 
While the association of derivative (1;18) with JAK2 
V617F still remain elusive, it is possible that that 
patients having this chromosome abnormality together 
with the JAK2 V617F mutation may belong to the 
subgroup of patients with highly proliferative 
phenotype of MPN which potentially transforms into 
acute myeloid leukemia. 




This abnormality yields the net result of an extra / third 
copy of chromosome 1q and a deletion of chromosome 
18p. 
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